C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes (Links to an external site)

C-Path’s Translational Therapeutics Accelerator Announces New Grant Award for Drug Development Project in Type 1 Diabetes
TUCSON, Ariz., June 18, 2025 — Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) proudly announced today a $250,000 grant award aimed at developing a novel treatment for type 1 diabetes (T1D). Kyle Apley, Ph.D., Cory Berkland, Ph.D., and Peggy Kendall M.D., at Washington University in St. Louis, have received this TRxA award to advance […]

Dr. Jeremy Katcher to Offer Intralymphatic Immunotherapy (ILIT™) at Highlands Clinic

Dr. Jeremy Katcher to Offer Intralymphatic Immunotherapy (ILIT™) at Highlands Clinic
We are thrilled to announce that Dr. Jeremy Katcher will soon be offering Intralymphatic Immunotherapy (ILIT™) as a new treatment option at our Highlands clinic location. This innovative therapy offers a cutting-edge approach to allergy treatment, designed to improve patient outcomes in a more efficient manner. ILIT™ is a revolutionary treatment for patients suffering from […]